Soluble monomeric human programmed cell death-ligand 1 inhibits the functions of activated T cells by Zhaoduan Liang, Zhaoduan Liang, Wenfang Chen, Yunzhuo Guo, Yunzhuo Guo, Yuefei Ren, Yuefei Ren, Ye Tian, Wenxuan Cai, Yifeng Bao, Qi Liu, Peng Ding, Yi Li, Yi Li

Subjects: Get full text

Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients by Yang Zhang, Zongjuan Li, Yixing Chen, Ping Yang, Yong Hu, Zhaochong Zeng, Shisuo Du

Subjects: Get full text

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma by Inju Cho, Hansang Lee, Sang Eun Yoon, Kyung Ju Ryu, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim

Subjects: “…Soluble PD-L1…”
Get full text

Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients by Takeru Kashiwada, Ryotaro Takano, Ryotaro Takano, Fumihiko Ando, Fumihiko Ando, Shoko Kuroda, Yoshishige Miyabe, Yoshishige Miyabe, Ryuji Owada, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai

Subjects: “…soluble PD-L1…”
Get full text

The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study by Takashi Kurosaki, Kenji Chamoto, Kenji Chamoto, Shinichiro Suzuki, Hiroaki Kanemura, Seiichiro Mitani, Kaoru Tanaka, Hisato Kawakami, Yo Kishimoto, Yasuharu Haku, Katsuhiro Ito, Toshiyuki Sato, Chihiro Suminaka, Mami Yamaki, Yasutaka Chiba, Tomonori Yaguchi, Tomonori Yaguchi, Koichi Omori, Takashi Kobayashi, Kazuhiko Nakagawa, Tasuku Honjo, Hidetoshi Hayashi

Subjects: Get full text

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations by Yijun Jia, Xuefei Li, Chao Zhao, Shengxiang Ren, Chunxia Su, Guanghui Gao, Wei Li, Fei Zhou, Jiayu Li, Caicun Zhou

Subjects: “…soluble PD-L1…”
Get full text

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer by Mengke Niu, Yiming Liu, Ming Yi, Dechao Jiao, Kongming Wu, Kongming Wu

Subjects: Get full text

Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer by Fumihiko Ando, Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Ryotaro Takano, Yoshishige Miyabe, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Ryuji Ohashi, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai

Subjects: “…soluble PD-L1…”
Get full text

Prognostic significance of soluble PD-L1 in prostate cancer by Margarita Zvirble, Margarita Zvirble, Zilvinas Survila, Paulius Bosas, Paulius Bosas, Neringa Dobrovolskiene, Agata Mlynska, Agata Mlynska, Gintaras Zaleskis, Jurgita Jursenaite, Dainius Characiejus, Dainius Characiejus, Vita Pasukoniene

Subjects: Get full text

Prognostic Significance of Serum PD-L1 Level in Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Combination Cytotoxic Chemotherapy by Fu R, Jing CQ, Li XR, Tan ZF, Li HJ

Subjects: Get full text

Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA Vaccination by Pierre Tannig, Antonia Sophia Peter, Dennis Lapuente, Stephan Klessing, Anna Schmidt, Dominik Damm, Matthias Tenbusch, Klaus Überla, Vladimir Temchura

Subjects: Get full text

Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resec... by Junko Tanizaki, MD, PhD, Hiroaki Kuroda, MD, PhD, Toshihide Yokoyama, MD, Makoto Takahama, MD, PhD, Hiroyasu Shoda, MD, PhD, Atsushi Nakamura, MD, PhD, Yoshitaka Kitamura, MD, PhD, Nobuaki Mamesaya, MD, PhD, Yoshihisa Kadota, MD, PhD, Kenji Sawa, MD, PhD, Kyoichi Okishio, MD, PhD, Morihito Okada, MD, PhD, Chihiro Suminaka, MS, Kenta Noda, PhD, Kazuko Sakai, PhD, Yasutaka Chiba, PhD, Kazuto Nishio, MD, PhD, Kenji Chamoto, PhD, Tasuku Honjo, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Hidetoshi Hayashi, MD, PhD

Subjects: Get full text

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma by Christopher Montemagno, Anais Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Iovanna, Nathalie Rioux-Leclercq, Camillio Porta, Sylvie Negrier, Jean-Marc Ferrero, Emmanuel Chamorey, Gilles Pagès, Maeva Dufies

Subjects: Get full text

The potential of soluble programmed death-ligand 1 (sPD-L1) as a diagnosis marker for colorectal cancer by Weifang Shao, Yanhua Xu, Suzhen Lin, Junli Gao, Junshun Gao, Hong Wang

Subjects: Get full text

Corrigendum: Soluble PD−L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis by Takashi Shimizu, Takashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, Ryotaro Ohkuma, Shinichi Kobayashi, Takuya Tsunoda, Satoshi Wada, Satoshi Wada, Satoshi Wada, Satoshi Wada, Satoshi Wada

Subjects: “…soluble PD-L1…”
Get full text

Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis by Takashi Shimizu, Takashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, Ryotaro Ohkuma, Shinichi Kobayashi, Takuya Tsunoda, Satoshi Wada, Satoshi Wada, Satoshi Wada, Satoshi Wada, Satoshi Wada

Subjects: “…soluble PD-L1…”
Get full text

Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease by Ayaka Hayashi, Ayaka Hayashi, Hiroto Ishihara, Mayuko Kawabe, Kazuhiko Kato, Kazuhiko Kato, Akio Nakashima, Akio Nakashima, Izumi Yamamoto, Teppei Sakano, Teppei Sakano, Hiroe Kobashi, Makoto Morita, Makoto Morita, Takashi Yokoo, Mitsuyoshi Urashima

Subjects: Get full text

Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer by Paul Buderath, Esther Schwich, Christina Jensen, Peter A. Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebmann

Subjects: Get full text